Literature DB >> 8339123

The relation between class-specific serum rheumatoid factors and age in the general population.

D van Schaardenburg1, A M Lagaay, H G Otten, F C Breedveld.   

Abstract

Class-specific RFs were measured in serum samples obtained from 810 individuals in seven age categories between 20-100 yr old, who were randomly selected from the general population. There was a decline with age of the mean IgG-RF levels in the higher age categories, no change of the mean IgA-RF levels and a clear increase of the mean IgM-RF levels in the higher age categories. In most age categories, the percentage of increased levels of all three RF isotypes was higher in the general population than in the healthy control population, consisting of 100 blood donors. These observations suggest that reference values for serum RF should be age-specific and based on sera of individuals randomly selected from the population.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339123     DOI: 10.1093/rheumatology/32.7.546

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  19 in total

1.  Second generation automated anti-CCP test better predicts the clinical diagnosis of rheumatoid arthritis.

Authors:  Mohamed Elrefaei; Kristie Boose; Martha McGee; Teresa K Tarrant; Feng-Chang Lin; Jason P Fine; John L Schmitz
Journal:  J Clin Immunol       Date:  2011-11-10       Impact factor: 8.317

2.  Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors.

Authors:  S Bas; T V Perneger; E Kunzle; T L Vischer
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 3.  Rheumatoid arthritis in the elderly. Prevalence and optimal management.

Authors:  D van Schaardenburg
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 4.  Is preclinical autoimmunity benign?: The case of cardiovascular disease.

Authors:  Darcy S Majka; Rowland W Chang
Journal:  Rheum Dis Clin North Am       Date:  2014-09-17       Impact factor: 2.670

Review 5.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  [Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study].

Authors:  J L Chen; Y B Jin; Y F Wang; X Y Zhang; J Li; H H Yao; J He; C Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

7.  Rheumatoid factor positivity increases all-cause and cancer mortality: a cohort study.

Authors:  Joong Kyong Ahn; Jiwon Hwang; Yoosoo Chang; Seungho Ryu
Journal:  Rheumatol Int       Date:  2017-05-17       Impact factor: 2.631

Review 8.  Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?

Authors:  Zoltán Szekanecz; Lilla Soós; Zoltán Szabó; Andrea Fekete; Anikó Kapitány; Anikó Végvári; Sándor Sipka; Gabriella Szücs; Sándor Szántó; Gabriella Lakos
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

9.  Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis.

Authors:  Nermeen S A Abdel Fattah; Hanan E Hassan; Zenab A Galal; El Sayed E El Okda
Journal:  BMC Res Notes       Date:  2009-03-19

10.  Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.

Authors:  Jennie Ursum; Wouter H Bos; Rob J van de Stadt; Ben A C Dijkmans; Dirkjan van Schaardenburg
Journal:  Arthritis Res Ther       Date:  2009-05-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.